Surging global incidence of head and neck malignancies, expanding clinical adoption of immune checkpoint inhibitors, and continuous advancements in organ-preservation multimodality protocols are driving strong expansion across the global Hypopharyngeal Cancer Treatment Market. Hypopharyngeal cancer—a aggressive form of head and neck squamous cell carcinoma—presents unique clinical...